Dermatitis, Eczematous Unknown Status Phase 3 Trials for Desonide (DB01260)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02286700Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic DermatitisTreatment